首页> 美国卫生研究院文献>OncoTargets and therapy >Non-Hodgkin lymphoma and GIST: molecular pathways and clinical expressions
【2h】

Non-Hodgkin lymphoma and GIST: molecular pathways and clinical expressions

机译:非霍奇金淋巴瘤和GIST:分子途径和临床表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report the case of a 64-year-old woman with a gastrointestinal stromal tumor and a diffuse large cell lymphoma. For this case, we conducted a literature review in an attempt to correlate these two neoplasms on a molecular basis. Diffuse large cell lymphoma is a subtype of non-Hodgkin lymphomas. The etiologic factor of these lymphomas is considered to be the mutations or allelic losses of the TP53 tumor suppressor gene and the overexpression of the bcl-2 oncogene. Gastrointestinal stromal tumors are mesenchymal tumors, which are typically defined by the expression of c-KIT (CD117) and CD34 genes in the tumor cells. Although there are references to dispersants in the literature about patients with both non-Hodgkin lymphoma and gastrointestinal stromal tumors, there is no common molecular pathway between these two diseases. In conclusion, there is no indication that these two neoplasms are relevant on a molecular basis.
机译:我们报告了一名64岁女性患有胃肠道间质瘤和弥漫性大细胞淋巴瘤的病例。对于这种情况,我们进行了文献综述,试图在分子基础上关联这两个肿瘤。弥漫性大细胞淋巴瘤是非霍奇金淋巴瘤的一种亚型。这些淋巴瘤的病因被认为是TP53抑癌基因的突变或等位基因的丢失以及bcl-2癌基因的过度表达。胃肠道间质瘤是间充质肿瘤,通常由肿瘤细胞中c-KIT(CD117)和CD34基因的表达来定义。尽管在文献中有关于非霍奇金淋巴瘤和胃肠道间质瘤患者的分散剂参考,但这两种疾病之间没有共同的分子途径。总之,没有迹象表明这两种肿瘤在分子基础上是相关的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号